CIExpert today publishes ‘Critical Thinking 2026’, the most comprehensive research study into the UK’s Critical Illness and Income Protection markets. The ...
Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the ...
Bernstein upgraded both Cigna Group and CVS Health Corp to Outperform in separate notes on Thursday, arguing that sweeping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results